The pathological basis of myocardial hibernation

N G Frangogiannis1

  • 1Section of Cardiovascular Sciences, Baylor College of Medicine and the DeBakey Heart Center, The Methodist Hospital, Houston, Texas 77030, USA. ngf@bcm.tmc.edu

Insights

Myocardial hibernation is a reversible dysfunction in coronary artery disease patients. Understanding its pathological changes and inflammatory mechanisms is key to preventing irreversible heart damage.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Molecular Biology

Background:

  • Myocardial hibernation is a key concept in ischemic cardiomyopathy, representing reversible ventricular dysfunction in coronary artery disease.
  • It arises from chronic hypoperfusion or repeated ischemia, impacting myocardial contractile function.
  • Developing reliable animal models for studying myocardial hibernation has been challenging.

Purpose of the Study:

  • To review the pathological alterations in hibernating myocardial segments.
  • To discuss the potential mechanisms underlying the development of myocardial hibernation.
  • To highlight the role of inflammation in the progression of myocardial dysfunction.

Main Methods:

  • Review of pathological findings in hibernating myocardial segments.
  • Discussion of proposed mechanistic pathways.
  • Analysis of inflammatory mediator involvement.

Main Results:

  • Consistent morphological alterations include depletion of contractile elements, myofilament loss, and cytoskeletal protein disorganization.
  • The cardiac interstitium shows inflammatory changes and fibrotic remodeling.
  • Cytokine and chemokine induction indicates an active inflammatory process contributing to fibrosis and dysfunction.

Conclusions:

  • Myocardial hibernation involves significant cellular and interstitial changes, including inflammation and fibrosis.
  • While initially adaptive, prolonged ischemia without revascularization leads to irreversible injury.
  • Targeting inflammatory mediators may offer therapeutic strategies to prevent fibrosis and dysfunction in ischemic cardiomyopathy.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...